Target intelligence / Profile preview

p38 Mitogen-Activated Protein Kinase (p38 MAPK)

Target
p38 MAPK
Molecular classification
Enzyme, Protein Kinase, Serine/Threonine Kinase, MAP Kinase, MAPK
01

Overview

p38 mitogen-activated protein kinases (MAPKs) are a class of serine/threonine protein kinases that play a central role in cellular responses to stress and inflammation. They are activated by various extracellular stimuli, including cytokines, ultraviolet irradiation, heat shock, osmotic shock, oxidative stress, and growth factors. The p38 MAPK pathway is evolutionarily conserved and is involved in regulating cell differentiation, apoptosis, autophagy, and inflammatory responses. There are four main isoforms: p38α (MAPK14), p38β (MAPK11), p38γ (MAPK12/ERK6), and p38δ (MAPK13/SAPK4). Activation typically follows a three-tiered kinase cascade: MAPKKKs activate MKKs, which phosphorylate p38 isoforms on a TGY motif. Activated p38 MAPKs phosphorylate numerous substrates, regulating inflammation, cell cycle arrest, and apoptosis. Given their role in inflammation, components of the p38 pathway are considered potential therapeutic targets for autoimmune diseases, chronic inflammatory conditions, neurodegenerative disorders, and cancer.

Other names
MAPK14MAPK11MAPK12MAPK13SAPK4ERK6
02

Mechanism of action

ATP-competitive inhibition (for small molecule inhibitors); Dephosphorylation by phosphatases (endogenous regulation)

03

Biological functions

Signal transductionStress responseInflammationCell cycle regulationApoptosisAutophagyCell differentiationGene expression regulation
04

Disease associations

Autoimmune diseasesChronic inflammatory conditionsNeurodegenerative disordersCancerInflammationInfection
05

Safety considerations

Potential for off-target effects due to kinase family similarityComplexity of the pathway and potential for unintended consequences
06

Interacting drugs

Small molecule inhibitors targeting ATP-binding sites

Beyond the preview

Go deeper on p38 Mitogen-Activated Protein Kinase (p38 MAPK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on p38 Mitogen-Activated Protein Kinase (p38 MAPK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call